MedPath

Gentian Violet

Generic Name
Gentian Violet
Drug Type
Small Molecule
Chemical Formula
C25H30N3
CAS Number
7438-46-2
Unique Ingredient Identifier
3GVJ31T6YY

Overview

A dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.

Background

A dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.

Indication

For the treatment of bacterial and fungal infections inside the mouth (thrush) and skin, also for the prevention of transmission of Chagas' disease (as a blood additive).

Associated Conditions

  • Bacterial Infection of the umbilical cord area
  • Fungal Infection of the umbilical cord area
  • Fungal Infections
  • Infection

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2020/05/14
Phase 2
Not yet recruiting
2011/09/02
Phase 3
Completed
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath